Landscapes / Targets
HGF
3 drugs act on HGF, in 3 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Phase 3 | Aug 2027Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | Aug 2027 · Phase 3 trial completes | ||||
| Also tested for | Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Dec 2028Phase 3 trial completes | |||
| Next date | 31 Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Acute Spinal Cord Injury (SCI) | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Vocal Fold Scar | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026